View Post

Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials

In Clinical Trials by Barbara Jacoby

From: prnewswire.com Feasibility Study Intends to Quantify PRP’s Active Ingredients in Human Serum Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that it has initiated development of a bio-analytical assay intended to quantify the active ingredients of the company’s lead product candidate, PRP, in preparation …

View Post

‘Killer peptide’ discovered that helps eliminate resistant cancer cells

In In The News by Barbara Jacoby

By: Allison Perry Source: University of Kentucky From: sciencedaily.com A new study by University of Kentucky Markey Cancer Center researchers shows that when therapy-sensitive cancer cells die, they release a “killer peptide” that can eliminate therapy-resistant cells. Tumor relapse is a common problem following cancer treatment, because primary tumor cells often contain therapy-resistance cancer cells that continue to proliferate after …

View Post

imILT® – immune stimulating Interstitial Laser Thermotherapy

In In The News by Barbara Jacoby

A novel therapy developed through the research of Swedish Professor Karl-Göran Tranberg and marketed by Clinical Laserthermia Systems AB (CLS). The principle behind the immune stimulating interstitial thermotherapy (imILT®) is simple, but the procedure requires great precision and control. The INTHER project will bring the groundbreaking immune stimulating Interstitial Laser Thermotherapy (imILT®) to the market and clinical practice. This minimally …

View Post

New drug trial shows promise in fighting cancer for CO woman

In In The News by Barbara Jacoby

By: Christine Noel, KUSA From: 9news.com This month, Joyce Brown is celebrating her 76th birthday, a milestone she worried two years ago she may not reach. In February 2014, Brown, a mother of five and grandmother of eight, was diagnosed with stage 4 ovarian cancer. “I was shocked when I learned I had cancer, I was scared” Brown said. “There …

View Post

Cancer cells’ stealth mechanism uncovered

In In The News by Barbara Jacoby

By: Michael Franco From: newsatlas.com When a malignant tumor invades the body, immune cells rush to the site to begin to fight it. When that same tumor spreads throughout the body, however, the cancer cells become invisible to our immune systems and can metastasize unencumbered by our natural defenses. Researchers out of the University of British Columbia (UBC) are on …

View Post

Research suggests new model for cancer metastasis

In In The News by Barbara Jacoby

By: Nicholas Weller From: medicalxpress.com Scientists at UC San Francisco have been able to directly observe, for the first time, how invasive cancer cells create a beachhead as they migrate to the lung in a mouse model of metastatic cancer. What they saw was utterly surprising: early “pioneer” cancer cells that lodge in the lung generally die, but first they …

FDA panel backs drug for early stage breast cancer

In In The News by Barbara Jacoby

by MATTHEW PERRONE Associated Press A biotech drug from Roche moved one step closer Thursday to becoming the first medicine approved to treat breast cancer before surgery. The Food and Drug Administration’s panel of cancer experts voted 13-0, with one abstention, that the benefits of Perjeta as an initial treatment for breast cancer outweigh its risks. The recommendation is not …

Nontoxic cancer therapy proves effective against metastatic cancer

In In The News by Barbara Jacoby

A combination of nontoxic dietary and hyperbaric oxygen therapies effectively increased survival time in a mouse model of aggressive metastatic cancer, a research team from the Hyperbaric Biomedical Research Laboratory at the University of South Florida has found. The study, “The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer,” was published online today in …